MEDI-3387

N/A

Report date: 2025/01/26 17:17:49

Base Information

Drug NameMEDI-3387

Drug Alias NamePD-1/GITRL bispecific fusion protein (Medimmune)dual PD-1 checkpoint inhibitor/GITR costimulator (Medimmune)MEDI-3387

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionGlucocorticoid-induced tumor necrosis factor receptor-related protein agonistsProgrammed cell death protein 1 blockers

TargetsGlucocorticoid-induced tumor necrosis factor receptor-related proteinProgrammed cell death protein 1

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesUnited Kingdom

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesMedimmune Llc

China Registration ClassN/A

Develop Information

Active CompaniesMedimmune Llc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A